Narae Nanotech Statistics
Total Valuation
Narae Nanotech has a market cap or net worth of KRW 33.90 billion. The enterprise value is 94.79 billion.
| Market Cap | 33.90B |
| Enterprise Value | 94.79B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Narae Nanotech has 11.06 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 11.06M |
| Shares Outstanding | 11.06M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 48.19% |
| Owned by Institutions (%) | n/a |
| Float | 5.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.59 |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | 33.38 |
| P/OCF Ratio | 25.91 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.69 |
| EV / Sales | 1.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 93.34 |
Financial Position
The company has a current ratio of 0.54, with a Debt / Equity ratio of 1.02.
| Current Ratio | 0.54 |
| Quick Ratio | 0.19 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 68.36 |
| Interest Coverage | -5.47 |
Financial Efficiency
Return on equity (ROE) is -21.78% and return on invested capital (ROIC) is -8.01%.
| Return on Equity (ROE) | -21.78% |
| Return on Assets (ROA) | -7.13% |
| Return on Invested Capital (ROIC) | -8.01% |
| Return on Capital Employed (ROCE) | -23.41% |
| Revenue Per Employee | 335.21M |
| Profits Per Employee | -97.37M |
| Employee Count | 171 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 3.30 |
Taxes
| Income Tax | -4.72B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.90% in the last 52 weeks. The beta is 0.71, so Narae Nanotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +9.90% |
| 50-Day Moving Average | 3,269.20 |
| 200-Day Moving Average | 3,261.90 |
| Relative Strength Index (RSI) | 37.02 |
| Average Volume (20 Days) | 67,369 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Narae Nanotech had revenue of KRW 57.32 billion and -16.65 billion in losses. Loss per share was -1,506.00.
| Revenue | 57.32B |
| Gross Profit | -7.25B |
| Operating Income | -18.49B |
| Pretax Income | -21.37B |
| Net Income | -16.65B |
| EBITDA | -12.94B |
| EBIT | -18.49B |
| Loss Per Share | -1,506.00 |
Balance Sheet
The company has 8.53 billion in cash and 69.42 billion in debt, giving a net cash position of -60.89 billion or -5,505.62 per share.
| Cash & Cash Equivalents | 8.53B |
| Total Debt | 69.42B |
| Net Cash | -60.89B |
| Net Cash Per Share | -5,505.62 |
| Equity (Book Value) | 68.10B |
| Book Value Per Share | 6,157.76 |
| Working Capital | -33.90B |
Cash Flow
In the last 12 months, operating cash flow was 1.31 billion and capital expenditures -292.72 million, giving a free cash flow of 1.02 billion.
| Operating Cash Flow | 1.31B |
| Capital Expenditures | -292.72M |
| Free Cash Flow | 1.02B |
| FCF Per Share | 91.83 |
Margins
Gross margin is -12.65%, with operating and profit margins of -32.25% and -29.05%.
| Gross Margin | -12.65% |
| Operating Margin | -32.25% |
| Pretax Margin | -37.28% |
| Profit Margin | -29.05% |
| EBITDA Margin | -22.58% |
| EBIT Margin | -32.25% |
| FCF Margin | 1.77% |
Dividends & Yields
Narae Nanotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -49.12% |
| FCF Yield | 3.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Narae Nanotech has an Altman Z-Score of 0.05 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.05 |
| Piotroski F-Score | 5 |